The Design Of A Double-Dummy, Active-Controlled, Multinational Phase-Iii Noninferiority Trial In 900 Patients With Partial-Onset Seizures: Eslicarbazepine Acetate Versus Controlled-Release Carbamazepine In Monotherapy
AuthID
P-002-P0E
P-002-P0E